Transcellular biosynthesis of eicosanoids

Polish Journal of Pharmacology

Volumn 51, Issue 2, 1999, Pages 113-117

  Gryglewski, R J ^a  

^a NONE

Author keywords

Aspirin induced asthma; Coronary disease; Eicosanoids; Glomerulonephritis; Thrombosis; Transcellular biosynthesis

Indexed keywords

ACETYLSALICYLIC ACID; ICOSANOID; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE E4; LIPOXIN; PEPTIDOLEUKOTRIENE; PROSTACYCLIN;

ALLERGIC ASTHMA; ANIMAL TISSUE; ENDOTHELIUM CELL; FATTY ACID SYNTHESIS; GLOMERULONEPHRITIS; GRANULOCYTE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; KIDNEY CELL; NONHUMAN; PSORIASIS; SHORT SURVEY; SKIN DISEASE; THROMBOCYTE; THROMBOSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; BLOOD PLATELETS; EICOSANOIDS; ENDOTHELIUM; GLOMERULONEPHRITIS; GRANULOCYTES; HUMANS; KIDNEY; MYOCARDIAL ISCHEMIA; THROMBOSIS;

EID: 0032943391     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. Bunting S., Gryglewski R. J., Moncada S., Vane J. R.: Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins, 1976, 12, 897-913.
2. Claria J., Lee M. H., Serhan C. N.: Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med., 1996, 2, 583-596.
3. Feinmark S. J.: The role of the endothelial cell in leukotriene biosynthesis. Amer. Rev. Respir. Dis., 1992, 146, S51-S55.
4. Fukai F., Suzuki Y., Nishizawa Y., Katayama T.: Transcellular biosynthesis of cysteinyl leukotrienes by Kupffer cell-hepatocyte cooperation in rat liver. Cell Biol. Int., 1996, 20, 423-428.
5. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R.: Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins, 1976, 12, 685-713.
6. Gryglewski R. J., Szczeklik A., Korbut R., Świȩs J., Musiał J., Krzanowski M., Maga P.: The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel - a new thromboxane synthase inhibitor. Wien. Klin. Wochenschr., 1995, 107, 283-289.
7. Hock C. E., Beck L. D., Papa L. A.: Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion. Cardiovasc. Res., 1992, 26, 1206-1211.
8. 4 into peptide leukotrienes: possible role in transcellular metabolism. Arch. Dermatol. Res., 1994, 286, 261-266.
9. Karim S., Habib A., Levy-Toledano S., Maclouf J.: Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J. Biol. Chem., 1996, 271, 12042-12048.
10. Korbut R., Dembińska-Kieć A., Świȩs J., Żmuda A., Gryglewski R. J.: On the mechanism of thrombolytic action of thromboxane synthetase inhibitors. Thromb. Haemost., 1987, 58, 827-830.
11. Marcus A. J., Weksler B. B., Jaffe E. A., Broekman M. J.: Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J. Clin. Invest., 1980, 66, 979-986.
12. 4 by transcellular biosynthesis. Proc. Nat. Acad. Sci. USA, 1986, 83, 1349-1353.
13. Mullane K., Hatala M. A., Kraemer R., Sessa W., Westlin W.: Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotriens. J. Cardiovasc. Pharmacol., 1987, 10, 398-406.
14. Nassar G. M., Badr K. F.: Role of leukotrienes and lipoxygenases in glomerular injury. Miner. Electrolyte Metab., 1995, 21, 262-270.
15. Needleman P., Wycke A., Raz A.: Platelet and blood vessel arachidonate metabolism and interactions. J. Clin. Invest., 1979, 63, 345-349.
16. Nowak J., FitzGerald G. A.: Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J. Clin. Invest., 1989, 83, 380-385.
17. Rossoni G., Sala A., Buccellati C., Maclouf J., Folco G. C., Berti F.: Vasoconstriction to polymorphonuclear leukocytes in the isolated, perfused rabbit heart: inhibition by prostacyclin mimetics. J. Cardiovasc. Pharmacol., 1996, 27, 680-685.
18. Sala A., Aliev G. M., Rossoni G., Berti F., Buccellati C., Burnstock G., Folco G., Maclouf J.: Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit. Blood, 1996, 87, 1824-1832.
19. 4 from human polymorphonuclear leukocytes. J. Biol. Chem., 1996, 271, 17944-17948.
20. 4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int. Arch. Allergy Immunol., 1997, 113, 355-357.
21. Scalia R., Kochilas L. I., Campbell B., Lefer A. M.: Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: role of P-selectin. Meth. Find. Exp. Clin. Pharmacol., 1996, 18, 669-676.
22. 4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest., 1990, 85, 772-780.
23. Szczeklik A.: Mechanisms of aspirin-induced asthma. Allergy, 1997, 52, 613-619.
24. Szczeklik A., Gryglewski R. J., Czerniawska-Mysik G.: Relationship of inhibition of prostaglandin biosynthesis by analgetics to asthma attacks in aspirin-sensitive patients. Brit. Med. J., 1975, 1, 67-69.